DNA Sequencing Market Outlook:
DNA Sequencing Market size was over USD 16.88 billion in 2025 and is anticipated to cross USD 108.95 billion by 2035, witnessing more than 20.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of DNA sequencing is assessed at USD 19.99 billion.
The demand for faster cancer diagnosis is one of the most prominent drivers to boost global DNA sequencing market growth during the forecast period. DNA sequencing has seen a broader use in various applications due to the rapid advances in bioinformatics. The rising cases of cancer globally have boosted the demand for advanced DNA sequencing to help identify the changes in the cancer genome.
DNA sequencing helps identify the DNA changes that can increase the cancer risks in an individual. As per a World Health Organization (WHO) report in February 2024, there were an estimated 20 million new cancer cases and 9.7 million deaths. The report stated that 1 in 5 people develop cancer in their lifetime. DNA sequencing can identify the acquired changes and help in choosing appropriate targeted therapies. National governments are now investing more in DNA sequencing research to expand the DNA sequencing market growth to streamline the future care of its citizens.
As per the current trends in DNA sequencing research, next-generation sequencing (NGS) has led to the ability to analyze DNA molecules accurately and cost-effectively. In April 2023, researchers at MIT and Harvard developed Concatenating Original Duplex for Error Correction (CODEC), which increases the efficacy of next-generation sequencing by 1000%. CODEC can monitor minute cancer mutations in blood samples and identify mutations leading to rare diseases. Groundbreaking research such as this is enhancing global DNA sequencing market growth.
